首页 > 最新文献

Arkhiv patologii最新文献

英文 中文
[The structure of pathogenic germline variants in colorectal cancer in Moscow patients]. [莫斯科结直肠癌患者致病性种系变异结构]。
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.17116/patol20238506116
A B Semenova, M M Byakhova, M V Makarova, V N Galkin, M V Nemtsova, D K Chernevskiy, A M Danishevich, V G Shatalov, A V Babkina, N G Popova, S M Gadzhieva
OBJECTIVE Describe the structure of pathogenic germline variants and clinical and anatomical features in colorectal cancer patients in Moscow. MATERIAL AND METHODS The whole genome sequencing results of patients with suspected hereditary cancer syndrome were evaluated. All identified genetic variants were validated using Sanger sequencing. RESULTS The study included 238 patients with colorectal cancer, 41/238 (17.2%) patients have pathogenic germline variants associated with hereditary cancer syndromes or increased cancer risk. Lynch syndrome accounts for 8% of all colorectal cancer cases (19/238), and familial adenomatous polyposis - 1.7% (4/238). 5 new genetic variants were described for the first time in a Russian colorectal cancer patients: MLH1 c.1921dup (p.Leu641fs), APC c.2929C>T (p.Gln977Ter), PMS2 c.327del (p.Ala110LeufsTer2), MSH2 c.1857dup (p. Val620CysfsTer24), ATM c.895G>T (p.Glu299Ter). In 197 of 238 patients, no significant variants were identified or variants with an uncertain clinical underlying cause were identified. CONCLUSION According to the results of the study, an earlier manifestation of a malignant neoplasm and a more frequent occurrence of high-grade carcinomas in the presence of pathogenic germline mutations were noted compared to the group of patients without clinically significant varianrs, while in the group with identified mutations, the frequency of regional and distant metastasis was not increased.
目的:描述莫斯科地区结直肠癌患者的致病种系变异结构和临床解剖学特征。材料与方法:对疑似遗传性癌症综合征患者的全基因组测序结果进行评价。所有鉴定的遗传变异均采用Sanger测序进行验证。结果:该研究纳入238例结直肠癌患者,其中41/238(17.2%)患者存在与遗传性癌症综合征或癌症风险增加相关的致病性种系变异。Lynch综合征占所有结直肠癌病例的8%(19/238),家族性腺瘤性息肉病占1.7%(4/238)。在俄罗斯结直肠癌患者中首次发现5个新的遗传变异:MLH1 c.1921dup (p. leu641fs)、APC c.2929C>T (p. gln977ter)、PMS2 c.327del (p. ala110leufster2)、MSH2 c.1857dup (p. val620cyfster24)、ATM c.895G>T (p. glu299ter)。在238例患者中,有197例未发现明显的变异,或发现临床根本原因不确定的变异。结论:根据研究结果,与无临床显著变异的患者相比,存在致病性种系突变的患者更早出现恶性肿瘤,更频繁发生高级别癌,而在已确定突变的患者中,区域和远处转移的频率未增加。
{"title":"[The structure of pathogenic germline variants in colorectal cancer in Moscow patients].","authors":"A B Semenova, M M Byakhova, M V Makarova, V N Galkin, M V Nemtsova, D K Chernevskiy, A M Danishevich, V G Shatalov, A V Babkina, N G Popova, S M Gadzhieva","doi":"10.17116/patol20238506116","DOIUrl":"10.17116/patol20238506116","url":null,"abstract":"OBJECTIVE Describe the structure of pathogenic germline variants and clinical and anatomical features in colorectal cancer patients in Moscow. MATERIAL AND METHODS The whole genome sequencing results of patients with suspected hereditary cancer syndrome were evaluated. All identified genetic variants were validated using Sanger sequencing. RESULTS The study included 238 patients with colorectal cancer, 41/238 (17.2%) patients have pathogenic germline variants associated with hereditary cancer syndromes or increased cancer risk. Lynch syndrome accounts for 8% of all colorectal cancer cases (19/238), and familial adenomatous polyposis - 1.7% (4/238). 5 new genetic variants were described for the first time in a Russian colorectal cancer patients: MLH1 c.1921dup (p.Leu641fs), APC c.2929C>T (p.Gln977Ter), PMS2 c.327del (p.Ala110LeufsTer2), MSH2 c.1857dup (p. Val620CysfsTer24), ATM c.895G>T (p.Glu299Ter). In 197 of 238 patients, no significant variants were identified or variants with an uncertain clinical underlying cause were identified. CONCLUSION According to the results of the study, an earlier manifestation of a malignant neoplasm and a more frequent occurrence of high-grade carcinomas in the presence of pathogenic germline mutations were noted compared to the group of patients without clinically significant varianrs, while in the group with identified mutations, the frequency of regional and distant metastasis was not increased.","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138443686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Study of FGFR2 status in gastric cancer by immunohistochemistry and fluorescent in situ hybridization]. [应用免疫组织化学和荧光原位杂交技术研究胃癌中FGFR2的状态]。
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.17116/patol20238503140
G A Raskin, M S Mukhina, E D Kravtsova, I V Tsimafeyeu, S A Tyulandin, N P Belyak, M A Kleshchev, R V Orlova

Background: Assessment of FGFR2 status in gastric cancer is an important task, without clarification of which it is impossible to identify a cohort of patients in whom the best response to treatment with anti-FGFR2 drugs could be obtained.

Objective: To conduct a comparative analysis of the expression and amplification of the FGFR2 gene in gastric cancer in primary tumors and metastases in the lymph nodes.

Material and methods: FGFR2 status was studied in 61 patients with stage III gastric adenocarcinoma using an immunohistochemical method (Abcam clone EPR24075-418, R&D clone 98706, Santa Cruz clone C-8, Abcam clone 1G3) and FISH.

Results: The antibody Abcam clone EPR24075-418 was found satisfactory for the immunohistochemical study of FGFR2. FGFR2 expression was detected in 26 (43%) cases, amplification in 5 (8%) cases. Amplification of FGFR2 in 4 cases out of 5 was accompanied by the expression of 3+, in 1 case - 2+. Discordance between FGFR2 expression in primary tumor and lymph node metastases was revealed in 13 (21%) cases.

Conclusion: Clone EPR24075-418 showed the best result in assessing the expression of FGFR2: the correlation with FISH results in reaction 3+ was 100%. Due to the high heterogeneity of FGFR2 expression, it is recommended to either examine the material of the primary tumor and metastasis, or evaluate a large volume of the primary tumor.

背景:评估胃癌中FGFR2的状态是一项重要的任务,如果不澄清这一点,就不可能确定一组患者对抗FGFR2药物治疗的最佳反应。目的:比较分析胃癌原发肿瘤和淋巴结转移灶中FGFR2基因的表达和扩增情况。材料和方法:采用免疫组织化学方法(Abcam克隆EPR24075-418, R&D克隆98706,Santa Cruz克隆C-8, Abcam克隆1G3)和FISH研究61例III期胃腺癌患者的FGFR2状态。结果:抗体Abcam克隆EPR24075-418可用于FGFR2的免疫组化研究。26例(43%)患者检测到FGFR2表达,5例(8%)患者检测到FGFR2扩增。5例中有4例FGFR2扩增伴有3+表达,1例- 2+表达。在13例(21%)原发肿瘤和淋巴结转移中发现FGFR2表达不一致。结论:克隆EPR24075-418对FGFR2表达的评估效果最好,与反应3+中FISH结果的相关性为100%。由于FGFR2表达的高度异质性,建议检查原发肿瘤和转移的材料,或评估原发肿瘤的大容量。
{"title":"[Study of FGFR2 status in gastric cancer by immunohistochemistry and fluorescent in situ hybridization].","authors":"G A Raskin,&nbsp;M S Mukhina,&nbsp;E D Kravtsova,&nbsp;I V Tsimafeyeu,&nbsp;S A Tyulandin,&nbsp;N P Belyak,&nbsp;M A Kleshchev,&nbsp;R V Orlova","doi":"10.17116/patol20238503140","DOIUrl":"https://doi.org/10.17116/patol20238503140","url":null,"abstract":"<p><strong>Background: </strong>Assessment of FGFR2 status in gastric cancer is an important task, without clarification of which it is impossible to identify a cohort of patients in whom the best response to treatment with anti-FGFR2 drugs could be obtained.</p><p><strong>Objective: </strong>To conduct a comparative analysis of the expression and amplification of the <i>FGFR2</i> gene in gastric cancer in primary tumors and metastases in the lymph nodes.</p><p><strong>Material and methods: </strong>FGFR2 status was studied in 61 patients with stage III gastric adenocarcinoma using an immunohistochemical method (Abcam clone EPR24075-418, R&D clone 98706, Santa Cruz clone C-8, Abcam clone 1G3) and FISH.</p><p><strong>Results: </strong>The antibody Abcam clone EPR24075-418 was found satisfactory for the immunohistochemical study of FGFR2. FGFR2 expression was detected in 26 (43%) cases, amplification in 5 (8%) cases. Amplification of <i>FGFR2</i> in 4 cases out of 5 was accompanied by the expression of 3+, in 1 case - 2+. Discordance between FGFR2 expression in primary tumor and lymph node metastases was revealed in 13 (21%) cases.</p><p><strong>Conclusion: </strong>Clone EPR24075-418 showed the best result in assessing the expression of FGFR2: the correlation with FISH results in reaction 3+ was 100%. Due to the high heterogeneity of FGFR2 expression, it is recommended to either examine the material of the primary tumor and metastasis, or evaluate a large volume of the primary tumor.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9577853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The use of digital radiography in the morphological evaluation of tumor response to neoadjuvant treatment of breast cancer]. 【数字x线摄影在乳腺癌新辅助治疗肿瘤反应形态学评价中的应用】。
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.17116/patol20238503146
I M Telezhnikova, L G Zhukova, S G Khomeriki, A B Abduraimov, N A Maksimov, G R Setdikova

Objective: To optimize the morphological assessment of tumor response to neoadjuvant therapy in breast cancer.

Material and methods: A retro- and prospective cohort study was conducted. The object of the study was the surgical material. Macroscopic parameters of residual tumor without and with the use of digital radiography (digital X-Ray) are described and analyzed. PathVision Faxitron imaging system was used for digital X-ray samples. An analysis of dynamics of clinical characteristics was carried out. Two methods of tumor bed examination were compared.

Results and discussion: The study cohort included 32 women, mean age 45.5±14 years. The correlation of the results of instrumental methods was 0.66 ([95% CI: 0.28; 1], p=0.0002). Microcalcinates were detected by digital X-Ray in 29 (90.6%) cases. Tumor bed sizes determined macroscopically (mean maximal size 6.1 (3.3) cm, median 5.2 (3.4-8.0) cm) and by using digital X-ray (mean maximal size 4.8 (2.6) cm, median 4.1 (2.7-6.2) cm), had statistically significant differences (p<0.0001). The agreement between the two methods of studying the tumor bed was 96.9%. The Cohen's kappa value was 0.95 (p<0.0001).

Conclusion: Morphological study is an integral part of clinical trials of drug efficacy. With the help of digital X-Ray, the identification of metal markers placed in the tumor bed and microcalcinates is facilitated by the morphologist, and the visibility of the boundaries of the tumor bed is also improved. The results obtained showed that the use of digital X-Ray can improve the accuracy of assessing the degree of morphological regression of breast cancer in response to treatment.

目的:优化乳腺癌新辅助治疗后肿瘤反应的形态学评价。材料和方法:进行回顾性和前瞻性队列研究。研究的对象是手术材料。描述和分析了无数字x线摄影和有数字x线摄影的残余肿瘤的宏观参数。数字x射线样品采用PathVision Faxitron成像系统。对临床特征进行动态分析。比较两种肿瘤床检方法。结果与讨论:研究队列包括32名女性,平均年龄45.5±14岁。仪器方法结果的相关性为0.66 (95% CI: 0.28;1], p = 0.0002)。29例(90.6%)经数字x线检查发现微煅烧物。宏观测定的肿瘤床大小(平均最大尺寸6.1 (3.3)cm,中位数5.2 (3.4-8.0)cm)与数字x线测定的肿瘤床大小(平均最大尺寸4.8 (2.6)cm,中位数4.1 (2.7-6.2)cm)差异有统计学意义(pp结论:形态学研究是药物疗效临床试验的重要组成部分。在数字x射线的帮助下,形态学家可以方便地识别放置在肿瘤床和微煅烧物中的金属标记物,也提高了肿瘤床边界的可见性。结果表明,使用数字x线可以提高评估乳腺癌治疗后形态消退程度的准确性。
{"title":"[The use of digital radiography in the morphological evaluation of tumor response to neoadjuvant treatment of breast cancer].","authors":"I M Telezhnikova,&nbsp;L G Zhukova,&nbsp;S G Khomeriki,&nbsp;A B Abduraimov,&nbsp;N A Maksimov,&nbsp;G R Setdikova","doi":"10.17116/patol20238503146","DOIUrl":"https://doi.org/10.17116/patol20238503146","url":null,"abstract":"<p><strong>Objective: </strong>To optimize the morphological assessment of tumor response to neoadjuvant therapy in breast cancer.</p><p><strong>Material and methods: </strong>A retro- and prospective cohort study was conducted. The object of the study was the surgical material. Macroscopic parameters of residual tumor without and with the use of digital radiography (digital X-Ray) are described and analyzed. PathVision Faxitron imaging system was used for digital X-ray samples. An analysis of dynamics of clinical characteristics was carried out. Two methods of tumor bed examination were compared.</p><p><strong>Results and discussion: </strong>The study cohort included 32 women, mean age 45.5±14 years. The correlation of the results of instrumental methods was 0.66 ([95% CI: 0.28; 1], <i>p</i>=0.0002). Microcalcinates were detected by digital X-Ray in 29 (90.6%) cases. Tumor bed sizes determined macroscopically (mean maximal size 6.1 (3.3) cm, median 5.2 (3.4-8.0) cm) and by using digital X-ray (mean maximal size 4.8 (2.6) cm, median 4.1 (2.7-6.2) cm), had statistically significant differences (<i>p</i><0.0001). The agreement between the two methods of studying the tumor bed was 96.9%. The Cohen's kappa value was 0.95 (<i>p</i><0.0001).</p><p><strong>Conclusion: </strong>Morphological study is an integral part of clinical trials of drug efficacy. With the help of digital X-Ray, the identification of metal markers placed in the tumor bed and microcalcinates is facilitated by the morphologist, and the visibility of the boundaries of the tumor bed is also improved. The results obtained showed that the use of digital X-Ray can improve the accuracy of assessing the degree of morphological regression of breast cancer in response to treatment.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9577856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Report on holding the IV Congress of Uzbekistan Pathologists with international participation, dedicated to the 90th anniversary of academician Malika Samatovna Abdullahodjaeva birth]. [关于举办第四届国际参与乌兹别克斯坦病理学家大会的报告,献给Malika Samatovna Abdullahodjaeva院士诞辰90周年]。
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.17116/patol20238502166

Report on holding the IV Congress of Uzbekistan Pathologists with international participation, dedicated to the 90th anniversary of academician Malika Samatovna Abdullahodjaeva birth.

关于举办第四届国际参与乌兹别克斯坦病理学家大会的报告,献给Malika Samatovna Abdullahodjaeva院士诞辰90周年。
{"title":"[Report on holding the IV Congress of Uzbekistan Pathologists with international participation, dedicated to the 90th anniversary of academician Malika Samatovna Abdullahodjaeva birth].","authors":"","doi":"10.17116/patol20238502166","DOIUrl":"https://doi.org/10.17116/patol20238502166","url":null,"abstract":"<p><p>Report on holding the IV Congress of Uzbekistan Pathologists with international participation, dedicated to the 90th anniversary of academician Malika Samatovna Abdullahodjaeva birth.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9664912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Characteristics of PIK3CA gene mutations in Her2-low breast cancer]. [低her2乳腺癌中PIK3CA基因突变的特点]。
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.17116/patol2023850415
I A Pavlenko, P E Povilaitite, N S Makarevich, V Yu Kaciyaev, A V Petrov
BACKGROUND Mutations in the PIK3CA gene, encoding the catalytic subunit of the PI3K class IA p110α, is a common mechanism of activating of PI3K/AKT/mTOR pathway in breast cancer (BC). The detection of these mutations in patients with hormone-positive Her2-negative BC is of important clinical value, since they are the predictor of the sensitivity of the tumor to the PI3K inhibitor - alpelisib. According to the status of the Her2/neu expression, all patients with hormone-positive Her2-negative BC can be divided into two groups - with low expression of Her2/neu (IHC 1+; 2+, ISH-) and with a complete lack of expression of this protein (IHC 0). OBJECTIVE Establish whether there are differences of the PIK3CA gene mutations charasteristics in BC with luminal immunophenotype and low expression of Her2/neu in comparison with tumors in which Her2/neu expression is absent. MATERIAL AND METHODS The presence of PIK3CA mutations was determined using real-time PCR on 96 patient tissues of hormone-positive Her2-negative BC. Commercially available cobas PIK3CA Mutation Kit (Roche) and cobas z480 analyzer were used. RESULTS PIK3CA gene mutations were detected in 40 of 96 cases studied (41.6%). Most of them were localized in the exons 9 and 20, encoding helicase (p.E542K, p.E545X) or kinase (p.H1047X) domains of PI3K, respectively. The frequency of mutations in the exon 9 (p.E542K+p.E545X) was 2.6 times higher in Her2-low BC compared to tumors in which the Her2/neu expression was absent (p<0.05). There were no statistically significant differences in mutation frequency in the exon 20. CONCLUSION Statistically significant increase in the frequency of exon 9 mutations of the PIK3CA gene is specific for the group of patients with Her2-low BC. Our results supported the concept of Her2-low BCs as the unique entity and pointed out the need of their further study.
背景:PIK3CA基因的突变是PI3K IA类催化亚基p110α的编码,是乳腺癌(BC)中PI3K/AKT/mTOR通路激活的常见机制。在激素阳性her2阴性BC患者中检测这些突变具有重要的临床价值,因为它们是肿瘤对PI3K抑制剂alpelisib敏感性的预测因子。根据Her2/neu表达情况,所有激素阳性的Her2阴性BC患者可分为两组:Her2/neu低表达组(IHC 1+;目的:探讨Her2/neu低表达的BC患者PIK3CA基因突变特征与Her2/neu不表达的肿瘤患者是否存在差异。材料和方法:96例激素阳性her2阴性BC患者组织采用实时荧光定量PCR检测PIK3CA突变的存在。使用市售cobas PIK3CA突变试剂盒(Roche)和cobas z480分析仪。结果:96例病例中检出PIK3CA基因突变40例(41.6%)。它们大多位于PI3K的外显子9和20,分别编码解旋酶(p.E542K, p.E545X)和激酶(p.H1047X)结构域。与Her2/neu表达缺失的肿瘤相比,Her2-low BC中外显子9 (p.E542K+p.E545X)的突变频率高2.6倍(p结论:PIK3CA基因外显子9突变频率的显著增加是Her2-low BC患者组特有的。我们的研究结果支持了Her2-low bc作为独特实体的概念,并指出了其进一步研究的必要性。
{"title":"[Characteristics of PIK3CA gene mutations in Her2-low breast cancer].","authors":"I A Pavlenko,&nbsp;P E Povilaitite,&nbsp;N S Makarevich,&nbsp;V Yu Kaciyaev,&nbsp;A V Petrov","doi":"10.17116/patol2023850415","DOIUrl":"https://doi.org/10.17116/patol2023850415","url":null,"abstract":"BACKGROUND Mutations in the PIK3CA gene, encoding the catalytic subunit of the PI3K class IA p110α, is a common mechanism of activating of PI3K/AKT/mTOR pathway in breast cancer (BC). The detection of these mutations in patients with hormone-positive Her2-negative BC is of important clinical value, since they are the predictor of the sensitivity of the tumor to the PI3K inhibitor - alpelisib. According to the status of the Her2/neu expression, all patients with hormone-positive Her2-negative BC can be divided into two groups - with low expression of Her2/neu (IHC 1+; 2+, ISH-) and with a complete lack of expression of this protein (IHC 0). OBJECTIVE Establish whether there are differences of the PIK3CA gene mutations charasteristics in BC with luminal immunophenotype and low expression of Her2/neu in comparison with tumors in which Her2/neu expression is absent. MATERIAL AND METHODS The presence of PIK3CA mutations was determined using real-time PCR on 96 patient tissues of hormone-positive Her2-negative BC. Commercially available cobas PIK3CA Mutation Kit (Roche) and cobas z480 analyzer were used. RESULTS PIK3CA gene mutations were detected in 40 of 96 cases studied (41.6%). Most of them were localized in the exons 9 and 20, encoding helicase (p.E542K, p.E545X) or kinase (p.H1047X) domains of PI3K, respectively. The frequency of mutations in the exon 9 (p.E542K+p.E545X) was 2.6 times higher in Her2-low BC compared to tumors in which the Her2/neu expression was absent (p<0.05). There were no statistically significant differences in mutation frequency in the exon 20. CONCLUSION Statistically significant increase in the frequency of exon 9 mutations of the PIK3CA gene is specific for the group of patients with Her2-low BC. Our results supported the concept of Her2-low BCs as the unique entity and pointed out the need of their further study.","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9926800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[External quality control of immunohistochemical studies in pathomorphology: tasks, problems, solutions, development prospects]. 病理形态学免疫组化研究的外部质量控制:任务、问题、解决方案和发展前景。
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.17116/patol20238502148
L É Zavalishina, A I Vasilyeva, O A Kuznetsova, K A Skrypnikova, G A Frank

In 2022, the Quality Control Center for Immunohistochemical Studies of the Russian Medical Academy of Continuing Professional Education conducted 12 rounds of markers for breast, lung, prostate, bladder cancer with the participation of 83 laboratories. For the first time, a round was held to control the method of in situ hybridization in the diagnosis of breast cancer, and a digital round. Typical problems in carrying out immunohistochemical studies in oncomorphology have been identified and the importance of participation of laboratories in external control has been shown.

2022年,俄罗斯继续职业教育医学院免疫组织化学研究质量控制中心对乳腺癌、肺癌、前列腺癌、膀胱癌进行了12轮标志物检测,共有83个实验室参与。第一次举行了一次会议,以控制原位杂交方法在乳腺癌的诊断,并举行了一次数字会议。已经确定了在肿瘤形态学中进行免疫组织化学研究的典型问题,并表明了实验室参与外部控制的重要性。
{"title":"[External quality control of immunohistochemical studies in pathomorphology: tasks, problems, solutions, development prospects].","authors":"L É Zavalishina,&nbsp;A I Vasilyeva,&nbsp;O A Kuznetsova,&nbsp;K A Skrypnikova,&nbsp;G A Frank","doi":"10.17116/patol20238502148","DOIUrl":"https://doi.org/10.17116/patol20238502148","url":null,"abstract":"<p><p>In 2022, the Quality Control Center for Immunohistochemical Studies of the Russian Medical Academy of Continuing Professional Education conducted 12 rounds of markers for breast, lung, prostate, bladder cancer with the participation of 83 laboratories. For the first time, a round was held to control the method of <i>in situ</i> hybridization in the diagnosis of breast cancer, and a digital round. Typical problems in carrying out immunohistochemical studies in oncomorphology have been identified and the importance of participation of laboratories in external control has been shown.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9364110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pathoanatomical algorithm for differential diagnosis of Paget's disease of the breast]. 【乳腺Paget病的病理解剖鉴别诊断算法】。
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.17116/patol20238502132
M V Mnikhovich, A V Romanov, T V Bezuglova, S N Zorin, K V Bun'kov

Paget's disease of the breast is a rare type of cancer that affects the skin of the nipple and usually the areola. At the same time, most patients also have one or more tumors in the immediate vicinity of the focus of mammary Paget's disease. This tumor must be distinguished from normal or atypical Toker cells, and also differentiated from diseases such as Bowen's disease of the nipple and melanocytic lesions of the nipple and areola region, including nipple melanoma and BAP1-inactivated nevus (Wiesner nevus). Currently, there is no routine pathological diagnostic algorithm for these conditions. The aim of the work is to formulate a clear clinical and morphological algorithm for diagnosing Paget's disease of the breast and Toker cells, Bowen's disease of the nipple and areola, as well as melanoma and BAP1-inactivated nevi of the above localizations. Surgical material obtained from patients with Paget's disease of the breast (18), Toker cells of the nipple (2), Bowen's disease of the nipple (6), melanoma of the nipple (1), BAP1-inactivated nevus (1) was studied. The material was examined histologically with hematoxylin and eosin staining, Alcian blue and PAS reaction, as well as immunohistochemically with the following panel of antibodies: CD138, p53, CK8, CK7, HER2/neu, EMA, HMB-45, Melan A, S-100, p63, p16 and BAP1. An easy-to-learn pathoanatomical algorithm for diagnosing Paget's cancer has been developed, which will be especially useful for pathologists who encounter pathology of the nipple and areola in their work.

乳房佩吉特病是一种罕见的癌症,影响乳头皮肤,通常是乳晕。同时,大多数患者在乳腺佩吉特病的病灶附近也有一个或多个肿瘤。该肿瘤必须与正常或非典型Toker细胞区分,也必须与乳头Bowen病和乳头乳晕区黑色素细胞病变(包括乳头黑色素瘤和bap1灭活痣(Wiesner痣))等疾病区分。目前,对于这些疾病还没有常规的病理诊断算法。本工作旨在为乳腺Paget病和Toker细胞、乳头乳晕Bowen病以及上述部位的黑色素瘤和bap1失活痣的诊断制定明确的临床和形态学算法。研究了乳腺Paget病(18例)、乳头Toker细胞(2例)、乳头Bowen病(6例)、乳头黑色素瘤(1例)、bap1失活痣(1例)患者的手术材料。采用苏木精和伊红染色、阿利新蓝和PAS反应进行组织学检查,并采用以下抗体进行免疫组织化学检查:CD138、p53、CK8、CK7、HER2/neu、EMA、HMB-45、Melan A、S-100、p63、p16和BAP1。一种易于学习的诊断Paget癌的病理解剖算法已经被开发出来,这将对在工作中遇到乳头和乳晕病理的病理学家特别有用。
{"title":"[Pathoanatomical algorithm for differential diagnosis of Paget's disease of the breast].","authors":"M V Mnikhovich,&nbsp;A V Romanov,&nbsp;T V Bezuglova,&nbsp;S N Zorin,&nbsp;K V Bun'kov","doi":"10.17116/patol20238502132","DOIUrl":"https://doi.org/10.17116/patol20238502132","url":null,"abstract":"<p><p>Paget's disease of the breast is a rare type of cancer that affects the skin of the nipple and usually the areola. At the same time, most patients also have one or more tumors in the immediate vicinity of the focus of mammary Paget's disease. This tumor must be distinguished from normal or atypical Toker cells, and also differentiated from diseases such as Bowen's disease of the nipple and melanocytic lesions of the nipple and areola region, including nipple melanoma and BAP1-inactivated nevus (Wiesner nevus). Currently, there is no routine pathological diagnostic algorithm for these conditions. The aim of the work is to formulate a clear clinical and morphological algorithm for diagnosing Paget's disease of the breast and Toker cells, Bowen's disease of the nipple and areola, as well as melanoma and BAP1-inactivated nevi of the above localizations. Surgical material obtained from patients with Paget's disease of the breast (18), Toker cells of the nipple (2), Bowen's disease of the nipple (6), melanoma of the nipple (1), BAP1-inactivated nevus (1) was studied. The material was examined histologically with hematoxylin and eosin staining, Alcian blue and PAS reaction, as well as immunohistochemically with the following panel of antibodies: CD138, p53, CK8, CK7, HER2/neu, EMA, HMB-45, Melan A, S-100, p63, p16 and BAP1. An easy-to-learn pathoanatomical algorithm for diagnosing Paget's cancer has been developed, which will be especially useful for pathologists who encounter pathology of the nipple and areola in their work.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9364113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical and morphological characteristics of the atypical placentation spectrum in the uterus]. 【子宫不典型胎盘谱的临床及形态学特征】。
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.17116/patol20238502113
A P Milovanov, N V Nizyaeva, T V Fokina, N B Tikhonova, I A Kulikov, R G Shmakov

Background: The concern of the global community of gynecologists and obstetricians (FIGO) regarding the increase in the number of caesarean sections has resulted in the creation of a new classification, Placenta Accreta Spectrum (PAS), which presents degrees of villus invasion into the uterine wall.

Objective: Compare the main types of atypical placentation (AP) with the stages of PAS, to supplement and unify the clinical and morphological criteria AP.

Material and methods: Surgical material was examined from 73 women after metroplasty (n=61) and hysterectomies (n=12) from the regions of Russia, Moscow and the Moscow region for ingrown villi and from 10 women with a typical placenta location during the first cesarean section. A targeted cutting of material from the uteroplacental region was used, at least 10-12 pieces, with further H&E and Mallory staining.

Results: In the classification of AP, the terms «placenta accreta», «increta», «percreta» should be retained. It is necessary to single out pl. previa as a separate type. Attention is focused on the need to assess the depth of villi invasion accompanied by a layer of fibrinoid, the volume of scar tissue and the degree of disorganization of the myometrial bundles, the state of the vessels in the serous membrane. A new type of AP has been proposed - a sharp thinning of the lower segment of the uterus, due to the scar failure and the pressure of the growing amniotic sac, leading to atrophy and necrosis of the myometrium.

Conclusion: An integrated approach should be used to classify atypical placentation, taking into account not only the depth of villus invasion, but also anatomical and pathogenic factors in order to develop targeted methods of surgical treatment.

背景:全球妇科和产科医生(FIGO)对剖腹产数量增加的关注导致了一种新的分类,即胎盘增生谱(PAS),它表示绒毛侵入子宫壁的程度。目的:比较不典型胎盘(AP)的主要类型与分期,补充和统一不典型胎盘(PAS)的临床和形态学标准。材料和方法:对来自俄罗斯、莫斯科和莫斯科地区的73例子宫成形术(61例)和子宫切除术(12例)的向内生长绒毛患者和10例首次剖宫产时胎盘位置典型的患者进行手术材料检查。从子宫胎盘区域靶向切割材料,至少10-12片,进一步进行H&E和Mallory染色。结果:在AP的分类中,应保留“胎盘增积”、“胎盘增积”、“胎盘完全”等术语。有必要单独列出pli . previa作为一个单独的类型。关注的重点是需要评估绒毛浸润的深度,并伴有一层纤维蛋白,疤痕组织的体积和肌束的破坏程度,浆膜中的血管状态。一种新型的AP被提出——由于瘢痕衰竭和生长的羊膜囊的压力,子宫下部急剧变薄,导致子宫肌层萎缩和坏死。结论:不典型胎盘的分类应综合考虑绒毛浸润深度、解剖及致病因素,以制定有针对性的手术治疗方法。
{"title":"[Clinical and morphological characteristics of the atypical placentation spectrum in the uterus].","authors":"A P Milovanov,&nbsp;N V Nizyaeva,&nbsp;T V Fokina,&nbsp;N B Tikhonova,&nbsp;I A Kulikov,&nbsp;R G Shmakov","doi":"10.17116/patol20238502113","DOIUrl":"https://doi.org/10.17116/patol20238502113","url":null,"abstract":"<p><strong>Background: </strong>The concern of the global community of gynecologists and obstetricians (FIGO) regarding the increase in the number of caesarean sections has resulted in the creation of a new classification, Placenta Accreta Spectrum (PAS), which presents degrees of villus invasion into the uterine wall.</p><p><strong>Objective: </strong>Compare the main types of atypical placentation (AP) with the stages of PAS, to supplement and unify the clinical and morphological criteria AP.</p><p><strong>Material and methods: </strong>Surgical material was examined from 73 women after metroplasty (<i>n</i>=61) and hysterectomies (<i>n</i>=12) from the regions of Russia, Moscow and the Moscow region for ingrown villi and from 10 women with a typical placenta location during the first cesarean section. A targeted cutting of material from the uteroplacental region was used, at least 10-12 pieces, with further H&E and Mallory staining.</p><p><strong>Results: </strong>In the classification of AP, the terms «placenta accreta», «increta», «percreta» should be retained. It is necessary to single out pl. previa as a separate type. Attention is focused on the need to assess the depth of villi invasion accompanied by a layer of fibrinoid, the volume of scar tissue and the degree of disorganization of the myometrial bundles, the state of the vessels in the serous membrane. A new type of AP has been proposed - a sharp thinning of the lower segment of the uterus, due to the scar failure and the pressure of the growing amniotic sac, leading to atrophy and necrosis of the myometrium.</p><p><strong>Conclusion: </strong>An integrated approach should be used to classify atypical placentation, taking into account not only the depth of villus invasion, but also anatomical and pathogenic factors in order to develop targeted methods of surgical treatment.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9679031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Mortality of the Penza region population from diseases of the liver and biliary tract in 2021-2022]. 【2021-2022年奔萨地区人群因肝脏和胆道疾病的死亡率】。
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.17116/patol20238505160
M G Fedorova, E V Komarova, A V Kozlova, N O Cyplihin

A study was made of the structure of mortality of the population of the Penza region from diseases of the liver and biliary tract in 2021-2022. Data on registered deaths were analyzed, the main cause of which was non-tumor diseases of the liver and biliary tract (excluding hepatitis B, C). Statistical calculations were carried out using the STATISTICA program. Between April 2021 and April 2022, 285 deaths from diseases of the liver and biliary tract were identified. The proportion of the male population prevails over the female and is 57.5%. The largest number of deaths occurs in persons aged 45 to 59 years, the smallest - in people over the age of 90 years. There were no deaths from diseases of the liver and bile ducts among minors. Among the initial causes of death in the studied sample, cirrhosis of the liver (K74.6) is in the lead - 75.4%, in second place are gallbladder stones with acute cholecystitis (K80.0) - 4.9%, then - chronic hepatitis (K73.8) - 4.2%. The categories of the population that are at risk for mortality from diseases of the liver and biliary tract have been identified. Among males, the risk group is people aged 45-59 years, among women - 18-44 years. The risk of death among men is 14% higher than among women. The most likely cause of death is cirrhosis of the liver (the terminal stage of chronic liver pathology).

对2021-2022年奔萨地区人群因肝脏和胆道疾病死亡的结构进行了研究。分析了登记死亡的数据,其主要原因是肝脏和胆道的非肿瘤疾病(不包括乙型肝炎、丙型肝炎)。使用STATISTICA程序进行统计计算。2021年4月至2022年4月,共有285人死于肝脏和胆道疾病。男性人口的比例高于女性,为57.5%。死亡人数最多的是45至59岁的人,最小的是90岁以上的人。未成年人中没有死于肝脏和胆管疾病。在研究样本的最初死亡原因中,肝硬化(K74.6)居首位,占75.4%,其次是胆囊结石伴急性胆囊炎(K80.0),占4.9%,然后是慢性肝炎(K73.8),占4.2%。已经确定了肝和胆道疾病死亡风险人群的类别。在男性中,风险群体为45-59岁的人群,在女性中为18-44岁。男性的死亡风险比女性高14%。最可能的死亡原因是肝硬化(慢性肝脏病理的晚期)。
{"title":"[Mortality of the Penza region population from diseases of the liver and biliary tract in 2021-2022].","authors":"M G Fedorova,&nbsp;E V Komarova,&nbsp;A V Kozlova,&nbsp;N O Cyplihin","doi":"10.17116/patol20238505160","DOIUrl":"10.17116/patol20238505160","url":null,"abstract":"<p><p>A study was made of the structure of mortality of the population of the Penza region from diseases of the liver and biliary tract in 2021-2022. Data on registered deaths were analyzed, the main cause of which was non-tumor diseases of the liver and biliary tract (excluding hepatitis B, C). Statistical calculations were carried out using the STATISTICA program. Between April 2021 and April 2022, 285 deaths from diseases of the liver and biliary tract were identified. The proportion of the male population prevails over the female and is 57.5%. The largest number of deaths occurs in persons aged 45 to 59 years, the smallest - in people over the age of 90 years. There were no deaths from diseases of the liver and bile ducts among minors. Among the initial causes of death in the studied sample, cirrhosis of the liver (K74.6) is in the lead - 75.4%, in second place are gallbladder stones with acute cholecystitis (K80.0) - 4.9%, then - chronic hepatitis (K73.8) - 4.2%. The categories of the population that are at risk for mortality from diseases of the liver and biliary tract have been identified. Among males, the risk group is people aged 45-59 years, among women - 18-44 years. The risk of death among men is 14% higher than among women. The most likely cause of death is cirrhosis of the liver (the terminal stage of chronic liver pathology).</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41181931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Recurrent petrosal tumor: meningioma or solitary fibrous tumor?] 复发性岩膜瘤:脑膜瘤还是孤立性纤维瘤?]
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.17116/patol20238502127
E V Prozorenko, V B Karakhan, O P Bliznyukov, N V Sevyan

Intracranial meningeal solitary fibrous tumors (SFT) originating from mesenchymal tissue are much less common than those with lesions of the visceral pleura or liver and were isolated as a nosological form only in 1996. These tumors are identical in clinical manifestations, MRI and light microscopy data to meningiomas. The pathognomonic difference of SFT, according to the 5th edition of the WHO classification, is the detection of overexpression of the protein encoded by the STAT6 gene. Estimation of other immunohistochemical markers is variable. At the same time, SFT has a tendency to more frequent recurrence and delayed malignancy. Transitional forms are possible. To form a clearer nosological outline of the SFT, it is necessary to accumulate clinical observations. A case of a giant meningioma of the posterior cranial fossa, which recurred 18 years after total removal at a 5-year annual control, is presented. Light microscopy of both primary and recurrent tumors revealed fibrous meningioma (WHO GI). Immunohistochemically revealed diffuse overexpression of CD34 and CD99. Determining the expression of the STAT6 protein was not technically possible. This case is regarded as a meningioma of the posterior surface of the pyramid of the temporal bone, growing into the cavity of the IV ventricle, with late recurrence without malignancy, with specific immunohistochemical profile.

颅内脑膜孤立性纤维性肿瘤(SFT)起源于间质组织,远比内脏胸膜或肝脏病变少见,仅在1996年作为一种分科形式被分离出来。这些肿瘤在临床表现、MRI和光镜数据上与脑膜瘤相同。根据WHO第5版分类,SFT的病理差异在于STAT6基因编码蛋白的过表达检测。其他免疫组织化学标志物的估计是可变的。同时,SFT有更频繁复发和迟发性恶性肿瘤的趋势。过渡形式是可能的。为了形成更清晰的SFT的病分学轮廓,有必要积累临床观察。一个巨大的脑膜瘤的后颅窝,其复发后的18年,在5年的控制,完全切除,提出。原发和复发肿瘤的光镜检查显示纤维性脑膜瘤(WHO GI)。免疫组织化学显示CD34和CD99弥漫性过表达。测定STAT6蛋白的表达在技术上是不可能的。本病例为颞骨锥体后表面脑膜瘤,生长进入第四脑室腔,晚期复发无恶性,具有特异性免疫组化特征。
{"title":"[Recurrent petrosal tumor: meningioma or solitary fibrous tumor?]","authors":"E V Prozorenko,&nbsp;V B Karakhan,&nbsp;O P Bliznyukov,&nbsp;N V Sevyan","doi":"10.17116/patol20238502127","DOIUrl":"https://doi.org/10.17116/patol20238502127","url":null,"abstract":"<p><p>Intracranial meningeal solitary fibrous tumors (SFT) originating from mesenchymal tissue are much less common than those with lesions of the visceral pleura or liver and were isolated as a nosological form only in 1996. These tumors are identical in clinical manifestations, MRI and light microscopy data to meningiomas. The pathognomonic difference of SFT, according to the 5th edition of the WHO classification, is the detection of overexpression of the protein encoded by the <i>STAT6</i> gene. Estimation of other immunohistochemical markers is variable. At the same time, SFT has a tendency to more frequent recurrence and delayed malignancy. Transitional forms are possible. To form a clearer nosological outline of the SFT, it is necessary to accumulate clinical observations. A case of a giant meningioma of the posterior cranial fossa, which recurred 18 years after total removal at a 5-year annual control, is presented. Light microscopy of both primary and recurrent tumors revealed fibrous meningioma (WHO GI). Immunohistochemically revealed diffuse overexpression of CD34 and CD99. Determining the expression of the STAT6 protein was not technically possible. This case is regarded as a meningioma of the posterior surface of the pyramid of the temporal bone, growing into the cavity of the IV ventricle, with late recurrence without malignancy, with specific immunohistochemical profile.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9664910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Arkhiv patologii
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1